Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis.

Beiske GA, Holmøy T, Beiske AG, Johannessen SI, Johannessen Landmark C.

Mult Scler Int. 2015;2015:317859. doi: 10.1155/2015/317859. Epub 2015 Jun 29.

2.

WT1 and interferon-β-vitamin D association in MS: a longitudinal study.

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM.

Acta Neurol Scand. 2015 Jun 2. doi: 10.1111/ane.12448. [Epub ahead of print]

PMID:
26037530
3.

Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.

Hanssen KT, Beiske AG, Landrø NI, Hofoss D, Hessen E.

Acta Neurol Scand. 2015 May 8. doi: 10.1111/ane.12420. [Epub ahead of print]

PMID:
25952561
4.

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2015 Mar 15;280:21-8. doi: 10.1016/j.jneuroim.2015.02.001. Epub 2015 Feb 11.

PMID:
25773151
5.

Goal attainment in cognitive rehabilitation in MS patients.

Hanssen KT, Saltytė Benth J, Beiske AG, Landrø NI, Hessen E.

Neuropsychol Rehabil. 2015;25(1):137-54. doi: 10.1080/09602011.2014.971818. Epub 2014 Oct 30.

PMID:
25356835
6.

Real life cost and quality of life associated with continuous intraduodenal levodopa infusion compared with oral treatment in Parkinson patients.

Lundqvist C, Beiske AG, Reiertsen O, Kristiansen IS.

J Neurol. 2014 Dec;261(12):2438-45. doi: 10.1007/s00415-014-7515-4. Epub 2014 Oct 1.

PMID:
25270681
7.

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis.

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O.

Mult Scler. 2014 Dec;20(14):1833-40. doi: 10.1177/1352458514533843. Epub 2014 May 19.

PMID:
24842958
8.

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T.

J Neuroimmunol. 2014 Jun 15;271(1-2):60-5. doi: 10.1016/j.jneuroim.2014.03.014. Epub 2014 Mar 24.

PMID:
24713402
9.

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.

Holmøy T, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Saltytė Benth J, Torkildsen O, Wergeland S, Myhr KM, Michelsen AE, Aukrust P, Ueland T.

PLoS One. 2013 Sep 19;8(9):e75021. doi: 10.1371/journal.pone.0075021. eCollection 2013.

10.

Predictors of executive complaints and executive deficits in multiple sclerosis.

Hanssen KT, Beiske AG, Landrø NI, Hessen E.

Acta Neurol Scand. 2014 Apr;129(4):234-42. doi: 10.1111/ane.12177. Epub 2013 Aug 23.

PMID:
23980635
11.

Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T.

PLoS One. 2013;8(1):e54417. doi: 10.1371/journal.pone.0054417. Epub 2013 Jan 22.

12.

Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis.

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T.

Mult Scler. 2013 Apr;19(4):451-7. doi: 10.1177/1352458512457843. Epub 2012 Aug 20.

PMID:
22907941
13.

Sleep problems in Parkinson's disease: a community-based study in Norway.

Svensson E, Beiske AG, Loge JH, Beiske KK, Sivertsen B.

BMC Neurol. 2012 Aug 10;12:71. doi: 10.1186/1471-2377-12-71.

14.

Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients.

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T.

Neuroepidemiology. 2012;39(2):84-93. doi: 10.1159/000339360. Epub 2012 Jul 17.

15.

Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM.

Neurology. 2012 Jul 17;79(3):267-73. doi: 10.1212/WNL.0b013e31825fdf01. Epub 2012 Jun 13.

PMID:
22700809
16.

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.

Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Lilleås F, Pedersen T, Bjørnarå B, Dalene F, Kleveland G, Schepel J, Olsen IC, Myhr KM.

Arch Neurol. 2012 Aug;69(8):1044-51. doi: 10.1001/archneurol.2012.283.

PMID:
22507886
17.

Patient satisfaction in rehabilitation of patients with multiple sclerosis.

Holmøy T, Hanssen KT, Beiske AG.

Tidsskr Nor Laegeforen. 2012 Mar 6;132(5):523-6. doi: 10.4045/tidsskr.11.1043. English, Norwegian.

18.

[Neglect of chronically ill].

Beiske AG.

Tidsskr Nor Laegeforen. 2011 Dec 13;131(24):2462. doi: 10.4045/tidsskr.11.1070. Norwegian. No abstract available.

19.

Validation of the multiple sclerosis international quality of life (MusiQoL) questionnaire in Norwegian patients.

Beiske AG, Baumstarck K, Nilsen RM, Simeoni MC.

Acta Neurol Scand. 2012 Mar;125(3):171-9. doi: 10.1111/j.1600-0404.2011.01518.x. Epub 2011 Apr 7.

PMID:
21470195
20.

Fatigue in Parkinson's disease: prevalence and associated factors.

Beiske AG, Loge JH, Hjermstad MJ, Svensson E.

Mov Disord. 2010 Oct 30;25(14):2456-60. doi: 10.1002/mds.23372.

PMID:
20976741
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk